CONRIG PHARMA ApS: Financial statements 2021
CVR: 33373236
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -246,326 and a net result of DKK -308,167 compared with DKK -603,545 the year before. Equity in the 2021 report amounted to DKK -1,704,783.
- Gross Profit
- DKK -246,326
- Profit/Loss
- DKK -308,167
- Equity
- DKK -1,704,783
- Total Assets
- DKK 53,380
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -246 t. | -308 t. | -1.7 mio. | - |
| 2020 | - | -555 t. | -604 t. | -1.4 mio. | - |
| 2019 | - | -165 t. | -198 t. | -793 t. | - |
| 2018 | - | -388 t. | -398 t. | -595 t. | - |
| 2017 | - | -305 t. | -286 t. | -197 t. | - |
Official annual report
Find more companies like CONRIG PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
CONRIG PHARMA ApS has published its annual report for 2020. Gross profit came to DKK -555,136, and the net result was DKK -603,545.
About CONRIG PHARMA ApS
CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Lars Christer Fredrik Fåhraeus and Snickar Karl Johan Tobieson. The board consists of Lars Christer Fredrik Fåhraeus, Niels Skjærbæk and Snickar Karl Johan Tobieson. The company is owned by Melius Pharma AB. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.